GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ViaDerma Inc (OTCPK:VDRM) » Definitions » COGS-to-Revenue

ViaDerma (ViaDerma) COGS-to-Revenue : 0.67 (As of Jun. 2012)


View and export this data going back to 2008. Start your Free Trial

What is ViaDerma COGS-to-Revenue?

ViaDerma's Cost of Goods Sold for the three months ended in Jun. 2012 was $3.88 Mil. Its Revenue for the three months ended in Jun. 2012 was $5.82 Mil.

ViaDerma's COGS to Revenue for the three months ended in Jun. 2012 was 0.67.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. ViaDerma's Gross Margin % for the three months ended in Jun. 2012 was 33.37%.


ViaDerma COGS-to-Revenue Historical Data

The historical data trend for ViaDerma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ViaDerma COGS-to-Revenue Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
COGS-to-Revenue
- 0.59 0.57 0.62 0.70

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.65 0.71 0.77 0.72 0.67

ViaDerma COGS-to-Revenue Calculation

ViaDerma's COGS to Revenue for the fiscal year that ended in Dec. 2011 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=13.347 / 19.008
=0.70

ViaDerma's COGS to Revenue for the quarter that ended in Jun. 2012 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3.876 / 5.817
=0.67

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ViaDerma  (OTCPK:VDRM) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

ViaDerma's Gross Margin % for the three months ended in Jun. 2012 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 3.876 / 5.817
=33.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


ViaDerma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of ViaDerma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


ViaDerma (ViaDerma) Business Description

Traded in Other Exchanges
N/A
Address
4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.